Crossref
Which Psychedelic Therapy Should Rural Health Systems Pursue First: Psilocybin or Ibogaine?
The Permanente Journal · 05.11.2026 · 1-8
DOI: 10.7812/tpp/26.139 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Permanente Journal, online erschienen am 05.11.2026. Verfasst von Todd Davies und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Davies, T., & Coustasse, A. (2026). Which Psychedelic Therapy Should Rural Health Systems Pursue First: Psilocybin or Ibogaine?. The Permanente Journal, 1-8. https://doi.org/10.7812/tpp/26.139
Vancouver
Davies T, Coustasse A. Which Psychedelic Therapy Should Rural Health Systems Pursue First: Psilocybin or Ibogaine?. The Permanente Journal. 2026:1-8. doi:10.7812/tpp/26.139
BibTeX
@article{Davies2026,
author = {Davies, Todd and Coustasse, Alberto},
title = {Which Psychedelic Therapy Should Rural Health Systems Pursue First: Psilocybin or Ibogaine?},
journal = {The Permanente Journal},
year = {2026},
pages = {1--8},
doi = {10.7812/tpp/26.139}
}
EUVIMED